First in vivo magnetic particle imaging of lung perfusion in rats. (5th April 2017)

• Record Type: Journal Article
• Authors: Zhou, Xinyi Y; Jeffris, Kenneth E; Yu, Elaine Y; Zheng, Bo; Goodwill, Patrick W; Nahid, Payam; Conolly, Steven M
• Is Part Of: Physics in medicine & biology. Volume 62:Number 9(2017:May)
• Page Start: 3510
• Page End: 3522
• Publication Date: 2017-04-05
• Subjects: magnetic particle imaging -- lung perfusion -- lung imaging -- ventilation/perfusion; Biophysics -- Periodicals; Medical physics -- Periodicals; 610.153
• DOI: 10.1088/1361-6560/aa616c
• Languages: English
• ISSNs: 0031-9155

Abstract

Abstract: Pulmonary embolism (PE), along with the closely related condition of deep vein thrombosis, affect an estimated 600 000 patients in the US per year. Untreated, PE carries a mortality rate of 30%. Because many patients experience mild or non-specific symptoms, imaging studies are necessary for definitive diagnosis of PE. Iodinated CT pulmonary angiography is recommended for most patients, while nuclear medicine-based ventilation/perfusion (V/Q) scans are reserved for patients in whom the use of iodine is contraindicated. Magnetic particle imaging (MPI) is an emerging tracer imaging modality with high image contrast (no tissue background signal) and sensitivity to superparamagnetic iron oxide (SPIO) tracer. Importantly, unlike CT or nuclear medicine, MPI uses no ionizing radiation. Further, MPI is not derived from magnetic resonance imaging (MRI); MPI directly images SPIO tracers via their strong electronic magnetization, enabling deep imaging of anatomy including within the lungs, which is very challenging with MRI. Here, the first high-contrast in vivo MPI lung perfusion images of rats are shown using a novel lung perfusion agent, MAA-SPIOs.